"Case presentation
A 26-year-old Saudi female with no history of any medical issue presented with a 4-day history of shortness of breath, minimal excretion, and palpitation associated with pre-syncope and non-radiating chest pain. She had no history of trauma, surgery, cellulitis, lifting heavy weights, hormonal injections, or contraceptives.
The patient received the COVID-19, mRNA-type (Pfizer) vaccine second dose 4 days before her presentation. She received the first dose in May 2021 and the second dose in September 2021. Four days after the second dose, she presented to the Emergency Department... She did not have any medical condition and was in perfect state of health before her recent presentation ...
On suspicion of pulmonary embolism [PE], a chest CT scan was done and showed extensive pulmonary embolism. Radiology department reported the following findings; 'Extensive bilateral PE seen involving bilateral main pulmonary divisions extending to bilateral lobar and segmental branches, mainly middle and lower segments' ...
Discussion
... Vaccination became the foundation of the fight against COVID-19... Following mass production and administration of these vaccines, surveillance revealed some rare serious adverse effects not initially encountered in clinical trials. Among these adverse effects, thromboembolism was the most serious one.
© 2024 The Authors. Published by Elsevier Inc. on behalf of University of Washington.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).